Table 13.8

Adjusted Graft Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		(Tx 2004 - 2005)			(Tx 2004 - 2005)			(Tx 2002 - 2005)			(Tx 2000 - 2005)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	72	82.9%	4.5%	72	76.1%	5.2%	132	55.0%	5.2%	205	49.1%	4.2%
Primary Diagnosis	Congenital Disease	18	70.7%	10.6%	18	70.7%	10.6%	38	38.0%	9.5%	69	43.5%	6.4%
	Primary Pulmonary Hypertension	20	95.0%	4.8%	20	84.7%	8.0%	38	66.8%	9.6%	53	63.0%	8.4%
	Cystic Fibrosis	2	+	+	2	+	+	4	77.2%	17.5%	4	75.3%	18.6%
	Emphysema/COPD	1	+	+	1	+	+	1	+	+	4	46.8%	21.7%
	Other	13	75.1%	12.5%	13	57.7%	15.0%	16	54.9%	13.3%	22	34.3%	13.9%
	Unknown	18	84.7%	8.1%	18	79.5%	9.1%	35	60.9%	8.5%	53	49.9%	7.7%

Source: OPTN/SRTR Data as of May 1, 2007.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.